News

Hospitals Hurricane-Ready with Support from US Med-Equip

Patient-ready medical equipment available on-demand in case of any disasterHOUSTON, TX / ACCESSWIRE / May 30, 2024 / Hospitals along…

2 years ago

NeuPath Mind Wellness Launches Flagship Holistic Wellness Center in Delray Beach, Florida

Groundbreaking Facility to Merge Cutting-Edge Medical Innovations and Integrative Practices for Personal Health OptimizationDELRAY BEACH, FL / ACCESSWIRE / May…

2 years ago

Payers Target Current Challenges and Competitiveness With 2025 Tech Investment Surge, Reveals Black Book Research Survey

More Than 5,000 Health Plan IT Clients Evaluate 400 Software Firms, Advisors, and Service Vendors Across 35 Operational Areas in…

2 years ago

Theralase(R) Release’s 1Q2024 Financial Statements

TORONTO, ON / ACCESSWIRE / May 30, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")…

2 years ago

Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI operations installs, expanding care to more patients in more locations

Philips MR 5300 BlueSeal installation at Vida Imaging & Breast Center, Bayamon, Puerto Rico Exterior picture of Vida Imaging &…

2 years ago

Disc Medicine to Participate in the Jefferies Global Healthcare Conference

WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,…

2 years ago

New AAMI Guidance on Combination Products and FDA CGMPs

Arlington, Virginia, May 30, 2024 (GLOBE NEWSWIRE) -- As the breadth and scope of combination products around the world continues…

2 years ago

Johnson & Johnson MedTech gathers multi-disciplinary expert group to optimise lung cancer care and dialogue between patients and their healthcare team

ESTS - Congress site Palau de Congressos de Barcelona J&J symposium at the 32nd ESTS meeting in Barcelona, Spain J&J…

2 years ago

Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1

Commences the study, The Safety of Telomir-1 when Administered Orally to Geriatric Laboratory Beagle Dogs for 63 Consecutive Days study…

2 years ago

Ascendis to Spotlight Latest Updates for TransCon™ Rare Endocrinology Disease Portfolio at ENDO 2024

COPENHAGEN, Denmark, May 30, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that it will host informational…

2 years ago